The role of estrogen receptor β in transplacental cancer prevention by indole-3-carbinol

Cancer Prevention Research

Volumn 6, Issue 4, 2013, Pages 339-348

  Benninghoff, Abby D ^a   Williams, David E ^b,c  

^a UTAH STATE UNIVERSITY   (United States)

^b OREGON STATE UNIVERSITY   (United States)

^c OREGON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 INDOLEMETHANOL; CHRYSENE DERIVATIVE; ESTROGEN RECEPTOR BETA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GENE DOSAGE; GENOTYPE; HETEROZYGOSITY; LACTATION; LUNG CARCINOGENESIS; MALE; MATERNAL NUTRITION; MOUSE; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEX DIFFERENCE; TRANSPLACENTAL CARCINOGENESIS; TUMOR VOLUME;

ANIMALS; ANTICARCINOGENIC AGENTS; BENZOPYRENES; CARCINOGENS; CHEMOPREVENTION; DRUG EVALUATION, PRECLINICAL; ESTROGEN RECEPTOR BETA; FEMALE; INDOLES; MALE; MATERNAL-FETAL EXCHANGE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOPLASMS; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREGNANCY;

EID: 84877282646     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-12-0311     Document Type: Article

References (46)

1. Murillo G, Mehta RG. Cruciferous vegetables and cancer prevention. Nutr Cancer 2001;41:17-28. (Pubitemid 34666216)
2. Bradlow HL. Review. Indole-3-carbinol as a chemoprotective agent in breast and prostate cancer. In Vivo 2008;22:441-5.
3. Weng JR, Tsai CH, Kulp SK, Chen CS. Indole-3-carbinol as a chemopreventive and anti-cancer agent. Cancer Lett 2008;262:153-63.
4. Stoner G, Casto B, Ralston S, Roebuck B, Pereira C, Bailey G. Development of a multi-organ rat model for evaluating chemopreventive agents: efficacy of indole-3-carbinol. Carcinogenesis 2002;23: 265-72. (Pubitemid 34224001)
5. Oganesian A, Hendricks JD, Pereira CB, Orner GA, Bailey GS, Williams DE. Potency of dietary indole-3-carbinol as a promoter of aflatoxin B1-initiated hepatocarcinogenesis: results from a 9000 animal tumor study. Carcinogenesis 1999;20:453-8. (Pubitemid 29112634)
6. Kim YS, Milner JA. Targets for indole-3-carbinol in cancer prevention. J Nutr Biochem 2005;16:65-73. (Pubitemid 40170355)
7. Bostrom CE, Gerde P, Hanberg A, Jernstrom B, Johansson C, Kyrklund T, et al. Cancer risk assessment, indicators, and guidelines for polycyclic aromatic hydrocarbons in the ambient air. Environ Health Perspect 2002;110(Suppl 3):451-88. (Pubitemid 34669811)
8. Buters JT, Mahadevan B, Quintanilla-Martinez L, Gonzalez FJ, Greim H, Baird WM, et al. Cytochrome P450 1B1 determines susceptibility to dibenzo[a,l]pyrene-induced tumor formation. Chem Res Toxicol 2002; 15:1127-35.
9. Higginbotham S, RamaKrishna NV, Johansson SL, Rogan EG, Cavalieri EL. Tumor-initiating activity and carcinogenicity of dibenzo[a,l]pyrene versus 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene at low doses in mouse skin. Carcinogenesis 1993;14: 875-8. (Pubitemid 23169140)
10. Platt KL, Dienes HP, Tommasone M, Luch A. Tumor formation in the neonatal mouse bioassay indicates that the potent carcinogen dibenzo[def,p]chrysene (dibenzo[a,l]pyrene) is activated in vivo via its trans-11,12-dihydrodiol. Chem Biol Interact 2004;148: 27-36. (Pubitemid 38824658)
11. Reddy AP, Spitsbergen JM, Mathews C, Hendricks JD, Bailey GS. Experimental hepatic tumorigenicity by environmental hydrocarbon dibenzo[a,l]pyrene. J Environ Pathol Toxicol Oncol 1999;18:261-9. (Pubitemid 30140318)
12. Yu Z, Loehr CV, Fischer KA, Louderback MA, Krueger SK, Dashwood RH, et al. In utero exposure of mice to dibenzo[a,l]pyrene produces lymphoma in the offspring: role of the aryl hydrocarbon receptor. Cancer Res 2006;66:755-62. (Pubitemid 43165939)
13. Lightfoot TJ, Roman E. Causes of childhood leukaemia and lymphoma. Toxicol Appl Pharmacol 2004;199:104-17. (Pubitemid 39094529)
14. Yu Z, Mahadevan B, Lohr CV, Fischer KA, Louderback MA, Krueger SK, et al. Indole-3-carbinol in the maternal diet provides chemoprotection for the fetus against transplacental carcinogenesis by the polycyclic aromatic hydrocarbon dibenzo[a,l]pyrene. Carcinogenesis 2006;27:2116-23. (Pubitemid 44530586)
15. Auborn KJ, Fan S, Rosen EM, Goodwin L, Chandraskaren A, Williams DE, et al. Indole-3-carbinol is a negative regulator of estrogen. J Nutr 2003;133(7 Suppl):2470S-5S. (Pubitemid 36828856)
16. Meng Q, Yuan F, Goldberg ID, Rosen EM, Auborn K, Fan S. Indole-3-carbinol is a negative regulator of estrogen receptor-alpha signaling in human tumor cells. J Nutr 2000;130:2927-31. (Pubitemid 32005319)
17. Riby JE, Feng C, Chang YC, Schaldach CM, Firestone GL, Bjeldanes LF. The major cyclic trimeric product of indole-3-carbinol is a strong agonist of the estrogen receptor signaling pathway. Biochemistry 2000;39:910-8. (Pubitemid 30075317)
18. Sundar SN, Kerekatte V, Equinozio CN, Doan VB, Bjeldanes LF, Firestone GL. Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells. Mol Endocrinol 2006;20:3070-82. (Pubitemid 44833556)
19. Wang TT, Milner MJ, Milner JA, Kim YS. Estrogen receptor alpha as a target for indole-3-carbinol. J Nutr Biochem 2006;17:659-64. (Pubitemid 44380368)
20. Brandenberger AW, Tee MK, Lee JY, Chao V, Jaffe RB. Tissue distribution of estrogen receptors alpha (ER-alpha) and beta (ER-beta) mRNA in the midgestational human fetus. J Clin Endocrinol Metab 1997;82:3509-12. (Pubitemid 27419113)
21. Patrone C, Cassel TN, Pettersson K, Piao YS, Cheng G, Ciana P, et al. Regulation of postnatal lung development and homeostasis by estrogen receptor beta. Mol Cell Biol 2003;23:8542-52. (Pubitemid 37441291)
22. Stresser DM, Williams DE, Griffin DA, Bailey GS. Mechanisms of tumor modulation by indole-3-carbinol. Disposition and excretion in male Fischer 344 rats. Drug Metab Disposition 1995;23: 965-75.
23. Castro DJ, Yu Z, Lohr CV, Pereira CB, Giovanini JN, Fischer KA, et al. Chemoprevention of dibenzo[a,l]pyrene transplacental carcinogenesis in mice born to mothers administered green tea: primary role of caffeine. Carcinogenesis 2008;29:1581-6.
24. Castro DJ, Baird WM, Pereira CB, Giovanini J, Lohr CV, Fischer KA, et al. Fetal mouse Cyp1b1 and transplacental carcinogenesis from maternal exposure to dibenzo(a,l)pyrene. Cancer Prev Res 2008;1: 128-34.
25. Oganesian A, Hendricks JD, Williams DE. Long term dietary indole-3-carbinol inhibits diethylnitrosamine-initiated hepatocarcinogenesis in the infant mouse model. Cancer Lett 1997;118:87-94. (Pubitemid 27397228)
26. Chang YC, Riby J, Chang GH, Peng BC, Firestone G, Bjeldanes LF. Cytostatic and antiestrogenic effects of 2-(indol-3-ylmethyl)-3,3'- diindolylmethane, a major in vivo product of dietary indole-3-carbinol. Biochem Pharmacol 1999;58:825-34. (Pubitemid 29329533)
27. Liu H, Wormke M, Safe SH, Bjeldanes LF. Indolo[3,2-b]carbazole: a dietary-derived factor that exhibits both antiestrogenic and estrogenic activity. J Natl Cancer Inst 1994;86:1758-65. (Pubitemid 24373450)
28. Riby JE, Chang GH, Firestone GL, Bjeldanes LF. Ligand-independent activation of estrogen receptor function by 3,3'-diindolylmethane in human breast cancer cells. Biochem Pharmacol 2000;60:167-77. (Pubitemid 30312944)
29. Chen I, McDougal A, Wang F, Safe S. Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane. Carcinogenesis 1998;19:1631-9. (Pubitemid 28441867)
30. Wang TT, Schoene NW, Milner JA, Kim YS. Broccoli-derived phytochemicals indole-3-carbinol and 3,3'-diindolylmethane exerts concentration-dependent pleiotropic effects on prostate cancer cells: comparison with other cancer preventive phytochemicals. Mol Carcinog 2012;51:244-56.
31. Marconett CN, Sundar SN, Poindexter KM, Stueve TR, Bjeldanes LF, Firestone GL. Indole-3-carbinol triggers aryl hydrocarbon receptor-dependent estrogen receptor (ER)alpha protein degradation in breast cancer cells disrupting an ERalpha-GATA3 transcriptional cross-regulatory loop. Mol Biol Cell 2010;21:1166-77.
32. Shilling AD, Carlson DB, Katchamart S, Williams DE. 3,3'- Diindolylmethane, a major condensation product of indole-3-carbinol, is a potent estrogen in the rainbow trout. Toxicol Appl Pharmacol 2001; 170:191-200. (Pubitemid 32215850)
33. Tilton SC, Givan SA, Pereira CB, Bailey GS, Williams DE. Toxicoge-nomic profiling of the hepatic tumor promoters indole-3-carbinol, 17β-estradiol and β-naphthoflavone in rainbow trout. Toxicol Sci 2006;90: 61-72. (Pubitemid 43264727)
34. 1 cell cycle arrest of human breast cancer cells independent of estrogen receptor signaling. J Biol Chem 1998;273: 3838-47. (Pubitemid 28103238)
35. Carter TH, Liu K, Ralph W Jr, Chen D, Qi M, Fan S, et al. Diindolylmethane alters gene expression in human keratinocytes in vitro. J Nutr 2002;132:3314-24. (Pubitemid 35304238)
36. 1 arrest and apoptosis in human acute T-cell lymphoblastic leukemia cells. PLoS ONE 2012; 7:e34975.
37. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A 1996;93:5925-30. (Pubitemid 26190778)
38. Shim GJ, Gherman D, Kim HJ, Omoto Y, Iwase H, Bouton D, et al. Differential expression of oestrogen receptors in human secondary lymphoid tissues. J Pathol 2006;208:408-14. (Pubitemid 43210528)
39. Erlandsson MC, Ohlsson C, Gustafsson JA, Carlsten H. Role of oestrogen receptors alpha and beta in immune organ development and in oestrogen-mediated effects on thymus. Immunology 2001;103:17-25. (Pubitemid 32453095)
40. Shim GJ, Wang L, Andersson S, Nagy N, Kis LL, Zhang Q, et al. Disruption of the estrogen receptor beta gene in mice causes myeloproliferative disease resembling chronic myeloid leukemia with lymphoid blast crisis. Proc Natl Acad Sci U S A 2003;100:6694-9. (Pubitemid 36675339)
41. Skibola CF, Lightfoot T, Agana L, Smith A, Rollinson S, Kao A, et al. Polymorphisms in cytochrome P450 17A1 and risk of non-Hodgkin lymphoma. Br J Haematol 2005;129:618-21. (Pubitemid 40825823)
42. Skibola CF, Bracci PM, Paynter RA, Forrest MS, Agana L, Woodage T, et al. Polymorphisms and haplotypes in the cytochrome P450 17A1, prolactin, and catechol-O-methyltransferase genes and non-Hodgkin lymphoma risk. Cancer Epidemiol Biomarkers Prev 2005;14:2391-401. (Pubitemid 41437842)
43. Prescott E, Bjerg AM, Andersen PK, Lange P, Vestbo J. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur Respir J 1997;10:822-7. (Pubitemid 27180193)
44. Zang EA, Wynder EL. Differences in lung cancer risk between men and women: examination of the evidence. J Natl Cancer Inst 1996;88: 183-92. (Pubitemid 26065830)
45. Wu CT, Chang YL, Shih JY, Lee YC. The significance of estrogen receptor beta in 301 surgically treated non-small cell lung cancers. J Thorac Cardiovasc Surg 2005;130:979-86.
46. Schwartz AG, Prysak GM, Murphy V, Lonardo F, Pass H, Schwartz J, et al. Nuclear estrogen receptor beta in lung cancer: expression and survival differences by sex. Clin Cancer Res 2005;11:7280-7. (Pubitemid 41507685)